Determination of liver cancer risk after re

An analysis was performed on a cohort of 1,000 patients from 11 Andalusian hospitals. The project highlights the need for personalized medicine and individual assessment of patients with hepatitis C, even after recovering from this infection.

“Once the infection is cured, the prognosis for patients changes dramatically, with a reduced number of patients who will suffer complications derived from the damage already suffered. In this sense, our results show that there are patients who remain at risk of liver cancer, although they have been cured of hepatitis C, and therefore must continue to be closely monitored, while there are others who continue with follow-up consultations but may actually be discharged due to their low risk,” concludes Dr. Ampuero. The combination of two steps, transient elastography and ultrasound, is described to identify patients at risk.

Current guidelines recommend post-recovery follow-up based on baseline data (i.e. lab tests or transient elastography before starting treatment), while the study also suggests consideration of changes after treatment for better risk stratification.

Javier Ampuero is also a professor at the University of Seville and co-researcher responsible for the SeLiver group in the field of liver diseases at the Institute of Biomedicine of Seville (IBiS), coordinated by Manuel Romero. Three researchers from CIBER for Liver and Digestive Diseases participated in this study.

Hepatitis C

Chronic hepatitis C infection is responsible for one of the most common liver diseases in the world and is one of the main indications for liver transplantation. Since the arrival of direct-acting antivirals, most patients can be cured in a few weeks and with few adverse effects, unlike before.

Professionals in the Digestive System Unit at Virgen del Rocío University Hospital have treated and cured more than 1,500 patients since 2015, when direct-acting antivirals arrived. Additionally, they are now focusing on detecting patients with unknown infection and, most importantly, determining which patients should be followed up in the healthcare system due to their risk of complications after recovery from hepatitis. vs.

Warning: AAAS and EurekAlert! are not responsible for the accuracy of press releases posted on EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.

Comments are closed.